PL EN


Preferences help
enabled [disable] Abstract
Number of results
2000 | 48 | 4 | 243-249
Article title

The Immunological effects of interleukin 2 therapy in HIV+ patients

Authors
Content
Title variants
Languages of publication
EN
Abstracts
EN
Human immunodeficiency virus (HIV) infection produces a profound impairment of immune functions that antiretroviral therapy is unable to restore. Because of its immuno-enhancing properties, interleukin 2 (IL-2) has been used as a therapeutic tool in HIV+ subjects. IL-2 produces an increase of CD4 and CD8 lymphocyte absolute counts that is preferentially due to the expansion of the ?naive? cells. In addition, IL-2 increases cytokine production from the cells of the immune system and is able to up-regulate the expression of cytokine receptors, such as the chemokine receptors CCR-5 and CXCR-4. Less informations on the IL-2 activity on the CD8 subset are available at the moment. The advent of highly active antiretroviral therapy has changed this scenario, making the IL-2 effects less clear-cut than previously hypothesized. We suggest that the ongoing studies will define the precise role of IL-2 in the therapy of HIV infection.
References
Document Type
REVIEW
Publication order reference
P. De Paoli, Department of Microbiology, Immunology and Virology, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy
YADDA identifier
bwmeta1.element.element-from-psjc-785e0b22-20a5-3e2a-a00c-7a43d2adf787
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.